Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1920 ARTÍCULOS , VIENDO DEL 1876 AL 1890

Pharmacological activities and therapeutic potential of Hyperoside in the treatment of Alzheimer's and Parkinson's diseases: A systemic review

Yuan J, Dong X, Zhou S, Nao J.

Neuroscience. 2024 Dec 17;563:136-147. doi: 10.1016/j.neuroscience.2024.10.048. Epub 2024 Nov 1.

Evaluating the robustness of DTI-ALPS in clinical context: a meta-analytic parallel on Alzheimer's and Parkinson's diseases

Costa T, Manuello J, Premi E, Mattioli I, Lasagna L, Lahoz CB, Cauda F, Duca S, Liloia D.

Sci Rep. 2024 Nov 2;14(1):26381. doi: 10.1038/s41598-024-78132-9.

The Effects of Chiropractic Spinal Adjustment on EEG in Adults with Alzheimer's and Parkinson's Disease: A Pilot Randomised Cross-over Trial

Navid MS, Niazi IK, Holt K, Nedergaard RB, Amjad I, Ghani U, Kumari N, Shafique M, Duehr J, Trager RJ, Haavik H.

J Integr Neurosci. 2024 May 11;23(5):98. doi: 10.31083/j.jin2305098.

Vitamin D and Brain Health in Alzheimer and Parkinson Disease

Philippou E, Hirsch MA, Heyn PC, van Wegen EEH, Darwish H.

Arch Phys Med Rehabil. 2024 Apr;105(4):809-812. doi: 10.1016/j.apmr.2023.10.023. Epub 2024 Jan 6.

Are high copper levels related to Alzheimer's and Parkinson's diseases? A systematic review and meta-analysis of articles published between 2011 and 2022

Scolari Grotto F, Glaser V.

Biometals. 2024 Feb;37(1):3-22. doi: 10.1007/s10534-023-00530-9. Epub 2023 Aug 18.

Prevalence of cerebral microbleeds in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia: A systematic review and meta-analysis

Chin KS, Holper S, Loveland P, Churilov L, Yassi N, Watson R.

Neurobiol Aging. 2024 Feb;134:74-83. doi: 10.1016/j.neurobiolaging.2023.11.006. Epub 2023 Nov 19.

Pathologically Confirmed Alzheimer's Disease Presenting as Clinical Parkinson's Disease, A Case Report

Mohammadzadeh N, Wu CK, Donahue JE, Friedman JH.

Mov Disord Clin Pract. 2024 Sep;11(9):1141-1144. doi: 10.1002/mdc3.14149. Epub 2024 Jun 22.

The Association Between Neurocognitive Disorders and Gustatory Dysfunction: A Systematic Review and Meta-Analysis

Mantovani E, Zanini A, Cecchini MP, Tamburin S.

Neuropsychol Rev. 2024 Mar;34(1):192-213. doi: 10.1007/s11065-023-09578-3. Epub 2023 Feb 20.

Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer's/Parkinson's diseases

Mahin A, Soman SP, Modi PK, Raju R, Keshava Prasad TS, Abhinand CS.

J Neurovirol. 2024 Feb;30(1):57-70. doi: 10.1007/s13365-023-01191-7. Epub 2024 Jan 2.

Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial

Weintraub D, Espay AJ, Sharma VD, Tariot PN, Abler V, Pathak S, Stankovic S.

Parkinsonism Relat Disord. 2024 Feb;119:105951. doi: 10.1016/j.parkreldis.2023.105951. Epub 2023 Dec 12.

Neuroinflammation as a Link in Parkinson's and Alzheimer's Diseases: A Systematic Review and Meta-Analysis

Tylutka A, Żabiński P, Walas Ł, Zembron-Lacny A.

Aging Dis. 2024 Dec 7;16(6):3584-3600. doi: 10.14336/AD.2024.1174.

Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease

Singulani MP, Ferreira AFF, Figueroa PS, Cuyul-Vásquez I, Talib LL, Britto LR, Forlenza OV.

Ageing Res Rev. 2024 Mar;95:102231. doi: 10.1016/j.arr.2024.102231. Epub 2024 Feb 15.

Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers

Ansari MA, Tripathi T, Venkidasamy B, Monziani A, Rajakumar G, Alomary MN, Alyahya SA, Onimus O, D'souza N, Barkat MA, Al-Suhaimi EA, Samynathan R, Thiruvengadam M.

Mol Neurobiol. 2024 May;61(5):3042-3089. doi: 10.1007/s12035-023-03730-z. Epub 2023 Nov 15.

Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies

Langerscheidt F, Wied T, Al Kabbani MA, van Eimeren T, Wunderlich G, Zempel H.

J Neurol. 2024 Jun;271(6):2992-3018. doi: 10.1007/s00415-024-12314-3. Epub 2024 Mar 30.

Application of CRISPR/Cas9 System in the Treatment of Alzheimer's Disease and Neurodegenerative Diseases

Rahimi A, Sameei P, Mousavi S, Ghaderi K, Hassani A, Hassani S, Alipour S.

Mol Neurobiol. 2024 Nov;61(11):9416-9431. doi: 10.1007/s12035-024-04143-2. Epub 2024 Apr 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias